Genetic Modification Therapies Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Platform Technology (Gene editing, Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies); Delivery Technology (AAV, Adenovirus, Lentivirus, Retrovirus, Others); End User (Hospitals, Diagnostics and Testing Laboratories, Academic and Research Organizations, Others); Disease (Cardiology, Oncology, Ophthalmology, Hematology, Musculoskeletal, Neurology, Others) and Geography

Report Code: TIPRE00018012 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Genetic modification therapy incorporates a functional gene into a cell-based therapy. The genetic modification generally occurs outside the body, but the resulting genetic change to the patient's DNA is permanent. The active payload comprise of the gene encoding for production of the therapeutic protein and gene controls that regulates production of the therapeutic gene. The vector, which may be either non-viral or viral, delivers the gene and gene control payload to the cells which are to be genetically modified. The most common cell types include T cells, and HSCs. Genetic modification has brought a milestone into medicine. Genetic modification is very crucial in treating severe diseases.

MARKET DYNAMICS

The key market drivers for Genetic Modification Therapies Market Includes, rising applications of genetic modification therapies into treatment of diseases and disorders. Moreover, technological advancement into biotechnology studies has also fueled market growth. Additionally, increasing R&D investments by pharmaceutical and biotechnology industries is also expected to boost market growth during forecast period. However, unethical use of technology along with lack of awareness about genetic medication therapy is expected to restrain market growth during forecast period.

MARKET SCOPE

The "Genetic Modification Therapies Market" is a specialized and in-depth study of the Biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Genetic Modification Therapies market with detailed market segmentation by platform technology, delivery technology, end user and disease. The Genetic Modification Therapies Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Genetic Modification Therapies Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Genetic Modification Therapies Market is segmented on the basis of platform technology, delivery technology, end user and disease. On the basis of platform technology the market is segmented as, gene therapy, gene editing, genetically modified cell therapies, RNA therapies. On the basis of delivery technology the market is segmented as, AAV, Adenovirus, lentivirus, retrovirus, others. On the basis of end user the market is segmented as, hospitals, diagnostics and testing laboratories, academic and research organizations, others. And on the basis of disease the market is segmented as, cardiology, oncology, ophthalmology, hematology, neurology and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Genetic Modification Therapies Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Genetic Modification Therapies Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Genetic Modification Therapies Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Genetic Modification Therapies Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Genetic Modification Therapies Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Genetic Modification Therapies Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Genetic Modification Therapies market in the global market. Below mentioned is the list of few companies engaged in the Genetic Modification Therapies Market.

The report also includes the profiles of key players in Genetic Modification Therapies Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Casebia Therapeutics
  •   Acer Therapeutics Inc.
  •   4D Molecular Therapeutics
  •   Beam Therapeutics
  •   Abeona Therapeutics
  •   Editas Medicine
  •   GE Healthcare
  •   Allergan Plc.
  •   Marcala Biotech
  •   Orchard Therapeutics

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genetic Modification Therapies Market - By Platform Technology
1.3.2 Genetic Modification Therapies Market - By Delivery Technology
1.3.3 Genetic Modification Therapies Market - By End User
1.3.4 Genetic Modification Therapies Market - By Disease
1.3.5 Genetic Modification Therapies Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GENETIC MODIFICATION THERAPIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. GENETIC MODIFICATION THERAPIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GENETIC MODIFICATION THERAPIES MARKET - GLOBAL MARKET ANALYSIS
6.1. GENETIC MODIFICATION THERAPIES - GLOBAL MARKET OVERVIEW
6.2. GENETIC MODIFICATION THERAPIES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. GENETIC MODIFICATION THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - PLATFORM TECHNOLOGY
7.1. OVERVIEW
7.2. PLATFORM TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. GENE EDITING
7.3.1. Overview
7.3.2. Gene editing Market Forecast and Analysis
7.4. GENE THERAPIES
7.4.1. Overview
7.4.2. Gene Therapies Market Forecast and Analysis
7.5. GENETICALLY MODIFIED CELL THERAPIES
7.5.1. Overview
7.5.2. Genetically Modified Cell Therapies Market Forecast and Analysis
7.6. RNA THERAPIES
7.6.1. Overview
7.6.2. RNA Therapies Market Forecast and Analysis
8. GENETIC MODIFICATION THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - DELIVERY TECHNOLOGY
8.1. OVERVIEW
8.2. DELIVERY TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. AAV
8.3.1. Overview
8.3.2. AAV Market Forecast and Analysis
8.4. ADENOVIRUS
8.4.1. Overview
8.4.2. Adenovirus Market Forecast and Analysis
8.5. LENTIVIRUS
8.5.1. Overview
8.5.2. Lentivirus Market Forecast and Analysis
8.6. RETROVIRUS
8.6.1. Overview
8.6.2. Retrovirus Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. GENETIC MODIFICATION THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTICS AND TESTING LABORATORIES
9.4.1. Overview
9.4.2. Diagnostics and Testing Laboratories Market Forecast and Analysis
9.5. ACADEMIC AND RESEARCH ORGANIZATIONS
9.5.1. Overview
9.5.2. Academic and Research Organizations Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. GENETIC MODIFICATION THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE
10.1. OVERVIEW
10.2. DISEASE MARKET FORECASTS AND ANALYSIS
10.3. CARDIOLOGY
10.3.1. Overview
10.3.2. Cardiology Market Forecast and Analysis
10.4. ONCOLOGY
10.4.1. Overview
10.4.2. Oncology Market Forecast and Analysis
10.5. OPHTHALMOLOGY
10.5.1. Overview
10.5.2. Ophthalmology Market Forecast and Analysis
10.6. HEMATOLOGY
10.6.1. Overview
10.6.2. Hematology Market Forecast and Analysis
10.7. MUSCULOSKELETAL
10.7.1. Overview
10.7.2. Musculoskeletal Market Forecast and Analysis
10.8. NEUROLOGY
10.8.1. Overview
10.8.2. Neurology Market Forecast and Analysis
10.9. OTHERS
10.9.1. Overview
10.9.2. Others Market Forecast and Analysis

11. GENETIC MODIFICATION THERAPIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Genetic Modification Therapies Market Overview
11.1.2 North America Genetic Modification Therapies Market Forecasts and Analysis
11.1.3 North America Genetic Modification Therapies Market Forecasts and Analysis - By Platform Technology
11.1.4 North America Genetic Modification Therapies Market Forecasts and Analysis - By Delivery Technology
11.1.5 North America Genetic Modification Therapies Market Forecasts and Analysis - By End User
11.1.6 North America Genetic Modification Therapies Market Forecasts and Analysis - By Disease
11.1.7 North America Genetic Modification Therapies Market Forecasts and Analysis - By Countries
11.1.7.1 United States Genetic Modification Therapies Market
11.1.7.1.1 United States Genetic Modification Therapies Market by Platform Technology
11.1.7.1.2 United States Genetic Modification Therapies Market by Delivery Technology
11.1.7.1.3 United States Genetic Modification Therapies Market by End User
11.1.7.1.4 United States Genetic Modification Therapies Market by Disease
11.1.7.2 Canada Genetic Modification Therapies Market
11.1.7.2.1 Canada Genetic Modification Therapies Market by Platform Technology
11.1.7.2.2 Canada Genetic Modification Therapies Market by Delivery Technology
11.1.7.2.3 Canada Genetic Modification Therapies Market by End User
11.1.7.2.4 Canada Genetic Modification Therapies Market by Disease
11.1.7.3 Mexico Genetic Modification Therapies Market
11.1.7.3.1 Mexico Genetic Modification Therapies Market by Platform Technology
11.1.7.3.2 Mexico Genetic Modification Therapies Market by Delivery Technology
11.1.7.3.3 Mexico Genetic Modification Therapies Market by End User
11.1.7.3.4 Mexico Genetic Modification Therapies Market by Disease
11.2. EUROPE
11.2.1 Europe Genetic Modification Therapies Market Overview
11.2.2 Europe Genetic Modification Therapies Market Forecasts and Analysis
11.2.3 Europe Genetic Modification Therapies Market Forecasts and Analysis - By Platform Technology
11.2.4 Europe Genetic Modification Therapies Market Forecasts and Analysis - By Delivery Technology
11.2.5 Europe Genetic Modification Therapies Market Forecasts and Analysis - By End User
11.2.6 Europe Genetic Modification Therapies Market Forecasts and Analysis - By Disease
11.2.7 Europe Genetic Modification Therapies Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Genetic Modification Therapies Market
11.2.7.1.1 Germany Genetic Modification Therapies Market by Platform Technology
11.2.7.1.2 Germany Genetic Modification Therapies Market by Delivery Technology
11.2.7.1.3 Germany Genetic Modification Therapies Market by End User
11.2.7.1.4 Germany Genetic Modification Therapies Market by Disease
11.2.7.2 France Genetic Modification Therapies Market
11.2.7.2.1 France Genetic Modification Therapies Market by Platform Technology
11.2.7.2.2 France Genetic Modification Therapies Market by Delivery Technology
11.2.7.2.3 France Genetic Modification Therapies Market by End User
11.2.7.2.4 France Genetic Modification Therapies Market by Disease
11.2.7.3 Italy Genetic Modification Therapies Market
11.2.7.3.1 Italy Genetic Modification Therapies Market by Platform Technology
11.2.7.3.2 Italy Genetic Modification Therapies Market by Delivery Technology
11.2.7.3.3 Italy Genetic Modification Therapies Market by End User
11.2.7.3.4 Italy Genetic Modification Therapies Market by Disease
11.2.7.4 Spain Genetic Modification Therapies Market
11.2.7.4.1 Spain Genetic Modification Therapies Market by Platform Technology
11.2.7.4.2 Spain Genetic Modification Therapies Market by Delivery Technology
11.2.7.4.3 Spain Genetic Modification Therapies Market by End User
11.2.7.4.4 Spain Genetic Modification Therapies Market by Disease
11.2.7.5 United Kingdom Genetic Modification Therapies Market
11.2.7.5.1 United Kingdom Genetic Modification Therapies Market by Platform Technology
11.2.7.5.2 United Kingdom Genetic Modification Therapies Market by Delivery Technology
11.2.7.5.3 United Kingdom Genetic Modification Therapies Market by End User
11.2.7.5.4 United Kingdom Genetic Modification Therapies Market by Disease
11.2.7.6 Rest of Europe Genetic Modification Therapies Market
11.2.7.6.1 Rest of Europe Genetic Modification Therapies Market by Platform Technology
11.2.7.6.2 Rest of Europe Genetic Modification Therapies Market by Delivery Technology
11.2.7.6.3 Rest of Europe Genetic Modification Therapies Market by End User
11.2.7.6.4 Rest of Europe Genetic Modification Therapies Market by Disease
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Genetic Modification Therapies Market Overview
11.3.2 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis
11.3.3 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis - By Platform Technology
11.3.4 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis - By Delivery Technology
11.3.5 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis - By End User
11.3.6 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis - By Disease
11.3.7 Asia-Pacific Genetic Modification Therapies Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Genetic Modification Therapies Market
11.3.7.1.1 Australia Genetic Modification Therapies Market by Platform Technology
11.3.7.1.2 Australia Genetic Modification Therapies Market by Delivery Technology
11.3.7.1.3 Australia Genetic Modification Therapies Market by End User
11.3.7.1.4 Australia Genetic Modification Therapies Market by Disease
11.3.7.2 China Genetic Modification Therapies Market
11.3.7.2.1 China Genetic Modification Therapies Market by Platform Technology
11.3.7.2.2 China Genetic Modification Therapies Market by Delivery Technology
11.3.7.2.3 China Genetic Modification Therapies Market by End User
11.3.7.2.4 China Genetic Modification Therapies Market by Disease
11.3.7.3 India Genetic Modification Therapies Market
11.3.7.3.1 India Genetic Modification Therapies Market by Platform Technology
11.3.7.3.2 India Genetic Modification Therapies Market by Delivery Technology
11.3.7.3.3 India Genetic Modification Therapies Market by End User
11.3.7.3.4 India Genetic Modification Therapies Market by Disease
11.3.7.4 Japan Genetic Modification Therapies Market
11.3.7.4.1 Japan Genetic Modification Therapies Market by Platform Technology
11.3.7.4.2 Japan Genetic Modification Therapies Market by Delivery Technology
11.3.7.4.3 Japan Genetic Modification Therapies Market by End User
11.3.7.4.4 Japan Genetic Modification Therapies Market by Disease
11.3.7.5 South Korea Genetic Modification Therapies Market
11.3.7.5.1 South Korea Genetic Modification Therapies Market by Platform Technology
11.3.7.5.2 South Korea Genetic Modification Therapies Market by Delivery Technology
11.3.7.5.3 South Korea Genetic Modification Therapies Market by End User
11.3.7.5.4 South Korea Genetic Modification Therapies Market by Disease
11.3.7.6 Rest of Asia-Pacific Genetic Modification Therapies Market
11.3.7.6.1 Rest of Asia-Pacific Genetic Modification Therapies Market by Platform Technology
11.3.7.6.2 Rest of Asia-Pacific Genetic Modification Therapies Market by Delivery Technology
11.3.7.6.3 Rest of Asia-Pacific Genetic Modification Therapies Market by End User
11.3.7.6.4 Rest of Asia-Pacific Genetic Modification Therapies Market by Disease
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Genetic Modification Therapies Market Overview
11.4.2 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis
11.4.3 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis - By Platform Technology
11.4.4 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis - By Delivery Technology
11.4.5 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis - By End User
11.4.6 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis - By Disease
11.4.7 Middle East and Africa Genetic Modification Therapies Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Genetic Modification Therapies Market
11.4.7.1.1 South Africa Genetic Modification Therapies Market by Platform Technology
11.4.7.1.2 South Africa Genetic Modification Therapies Market by Delivery Technology
11.4.7.1.3 South Africa Genetic Modification Therapies Market by End User
11.4.7.1.4 South Africa Genetic Modification Therapies Market by Disease
11.4.7.2 Saudi Arabia Genetic Modification Therapies Market
11.4.7.2.1 Saudi Arabia Genetic Modification Therapies Market by Platform Technology
11.4.7.2.2 Saudi Arabia Genetic Modification Therapies Market by Delivery Technology
11.4.7.2.3 Saudi Arabia Genetic Modification Therapies Market by End User
11.4.7.2.4 Saudi Arabia Genetic Modification Therapies Market by Disease
11.4.7.3 U.A.E Genetic Modification Therapies Market
11.4.7.3.1 U.A.E Genetic Modification Therapies Market by Platform Technology
11.4.7.3.2 U.A.E Genetic Modification Therapies Market by Delivery Technology
11.4.7.3.3 U.A.E Genetic Modification Therapies Market by End User
11.4.7.3.4 U.A.E Genetic Modification Therapies Market by Disease
11.4.7.4 Rest of Middle East and Africa Genetic Modification Therapies Market
11.4.7.4.1 Rest of Middle East and Africa Genetic Modification Therapies Market by Platform Technology
11.4.7.4.2 Rest of Middle East and Africa Genetic Modification Therapies Market by Delivery Technology
11.4.7.4.3 Rest of Middle East and Africa Genetic Modification Therapies Market by End User
11.4.7.4.4 Rest of Middle East and Africa Genetic Modification Therapies Market by Disease
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Genetic Modification Therapies Market Overview
11.5.2 South and Central America Genetic Modification Therapies Market Forecasts and Analysis
11.5.3 South and Central America Genetic Modification Therapies Market Forecasts and Analysis - By Platform Technology
11.5.4 South and Central America Genetic Modification Therapies Market Forecasts and Analysis - By Delivery Technology
11.5.5 South and Central America Genetic Modification Therapies Market Forecasts and Analysis - By End User
11.5.6 South and Central America Genetic Modification Therapies Market Forecasts and Analysis - By Disease
11.5.7 South and Central America Genetic Modification Therapies Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Genetic Modification Therapies Market
11.5.7.1.1 Brazil Genetic Modification Therapies Market by Platform Technology
11.5.7.1.2 Brazil Genetic Modification Therapies Market by Delivery Technology
11.5.7.1.3 Brazil Genetic Modification Therapies Market by End User
11.5.7.1.4 Brazil Genetic Modification Therapies Market by Disease
11.5.7.2 Argentina Genetic Modification Therapies Market
11.5.7.2.1 Argentina Genetic Modification Therapies Market by Platform Technology
11.5.7.2.2 Argentina Genetic Modification Therapies Market by Delivery Technology
11.5.7.2.3 Argentina Genetic Modification Therapies Market by End User
11.5.7.2.4 Argentina Genetic Modification Therapies Market by Disease
11.5.7.3 Rest of South and Central America Genetic Modification Therapies Market
11.5.7.3.1 Rest of South and Central America Genetic Modification Therapies Market by Platform Technology
11.5.7.3.2 Rest of South and Central America Genetic Modification Therapies Market by Delivery Technology
11.5.7.3.3 Rest of South and Central America Genetic Modification Therapies Market by End User
11.5.7.3.4 Rest of South and Central America Genetic Modification Therapies Market by Disease

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. GENETIC MODIFICATION THERAPIES MARKET, KEY COMPANY PROFILES
13.1. CASEBIA THERAPEUTICS
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ACER THERAPEUTICS INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. 4D MOLECULAR THERAPEUTICS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BEAM THERAPEUTICS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ABEONA THERAPEUTICS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. EDITAS MEDICINE
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GE HEALTHCARE
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ALLERGAN PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MARCALA BIOTECH
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ORCHARD THERAPEUTICS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Casebia Therapeutics
2. Acer Therapeutics Inc
3. 4D Molecular Therapeutics
4. Beam Therapeutics
5. Abeona Therapeutics
6. Editas Medicine
7. GE Healthcare
8. Allergan Plc
9. Marcala Biotech
10. Orchard Therapeutics
TIPRE00018012
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking